Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hauschild

Showing results (781-790 of 1,351) with videos related to

Pageof 136
Sort By:
Melanoma Research|July 16, 2008
Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanomaAxel Hauschild, Uwe Trefzer, Claus Garbe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 25, 2013
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)Annette Degen, Michael Weichenthal, Selma Ugurel, et al.
Melanoma Research|January 28, 2014
Melanomas of unknown primary frequently harbor TERT-promoter mutationsFriederike Egberts, Sandra Krüger, Hans M Behrens, et al.
Der Orthopade|July 26, 2020
[Gluteal insufficiency]I J Banke, P M Prodinger, M Weber, et al.
Molecular Syndromology|February 15, 2024
Co-Occurrence of Myotonic Dystrophy Type 1 and Limb-Girdle Muscular Dystrophy Type 2B: A Case ReportLucas Augusto Hauschild, Taciana Seixas Maia da Silva, Pablo Brea Winckler, et al.
Environmental Microbiology|February 22, 2022
Biosolids for safe land application: does wastewater treatment plant size matters when considering antibiotics, pollutants, microbiome, mobile genetic elements and associated resistance genes?Birgit Wolters, Kristin Hauschild, Khald Blau, et al.
British Journal of Cancer|July 30, 2019
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanomaJason Chesney, Igor Puzanov, Frances Collichio, et al.
ACS Applied Materials & Interfaces|July 20, 2021
Sequential and Switchable Patterning for Studying Cellular Processes under Spatiotemporal ControlThemistoklis Zisis, Jan Schwarz, Miriam Balles, et al.
Journal of the Endocrine Society|August 27, 2025
Comparison of BoneXpert and IB-Lab-PANDA automated Bone Age Evaluation in Children With Growth and Puberty DisordersInge-Lore Ruiz-Arana, Victor Lechanteur, Kanetee Busiah, et al.
Melanoma Research|September 11, 2008
Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology GroupThomas K Eigentler, Peter Radny, Axel Hauschild, et al.
Pageof 136

Showing results (781-790 of 1,351) with videos related to

Sort By:
Pageof 136
Melanoma Research|July 16, 2008
Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanomaAxel Hauschild, Uwe Trefzer, Claus Garbe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 25, 2013
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)Annette Degen, Michael Weichenthal, Selma Ugurel, et al.
Melanoma Research|January 28, 2014
Melanomas of unknown primary frequently harbor TERT-promoter mutationsFriederike Egberts, Sandra Krüger, Hans M Behrens, et al.
Der Orthopade|July 26, 2020
[Gluteal insufficiency]I J Banke, P M Prodinger, M Weber, et al.
Molecular Syndromology|February 15, 2024
Co-Occurrence of Myotonic Dystrophy Type 1 and Limb-Girdle Muscular Dystrophy Type 2B: A Case ReportLucas Augusto Hauschild, Taciana Seixas Maia da Silva, Pablo Brea Winckler, et al.
Environmental Microbiology|February 22, 2022
Biosolids for safe land application: does wastewater treatment plant size matters when considering antibiotics, pollutants, microbiome, mobile genetic elements and associated resistance genes?Birgit Wolters, Kristin Hauschild, Khald Blau, et al.
British Journal of Cancer|July 30, 2019
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanomaJason Chesney, Igor Puzanov, Frances Collichio, et al.
ACS Applied Materials & Interfaces|July 20, 2021
Sequential and Switchable Patterning for Studying Cellular Processes under Spatiotemporal ControlThemistoklis Zisis, Jan Schwarz, Miriam Balles, et al.
Journal of the Endocrine Society|August 27, 2025
Comparison of BoneXpert and IB-Lab-PANDA automated Bone Age Evaluation in Children With Growth and Puberty DisordersInge-Lore Ruiz-Arana, Victor Lechanteur, Kanetee Busiah, et al.
Melanoma Research|September 11, 2008
Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology GroupThomas K Eigentler, Peter Radny, Axel Hauschild, et al.
Pageof 136